10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -255,099 | -166,000 | -58,223 | -542,731 | -31,251 |
| Depreciation Amortization | 43,619 | 33,006 | 28,254 | 19,021 | 7,066 |
| Accounts receivable | -10,613 | -18,948 | -34,041 | -17,847 | -5,284 |
| Accounts payable and accrued liabilities | -6,017 | 5,858 | 11,084 | -7,770 | 4,901 |
| Other Working Capital | 18,021 | -40,342 | -88,490 | -50,381 | 44,764 |
| Other Operating Activity | 194,892 | 152,820 | 120,043 | 381,810 | 14,431 |
| Operating Cash Flow | $-15,197 | $-33,606 | $-21,373 | $-217,898 | $34,627 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 183,016 | -215,226 | N/A | N/A | N/A |
| PPE Investments | -48,601 | -131,661 | -101,278 | -36,666 | -42,742 |
| Net Acquisitions | N/A | -4,000 | -5,451 | N/A | N/A |
| Purchase Sale Intangibles | -923 | N/A | N/A | -1,728 | -25 |
| Other Investing Activity | -923 | 0 | 0 | -1,728 | -25 |
| Investing Cash Flow | $133,492 | $-350,887 | $-106,729 | $-38,394 | $-42,767 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 11,000 |
| Debt Repayment | -5,814 | -5,409 | -5,028 | -37,104 | N/A |
| Common Stock Issued | 19,483 | 21,226 | 40,325 | 506,010 | 414,590 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -11,000 |
| Financing Cash Flow | $13,669 | $15,817 | $35,297 | $468,906 | $414,590 |
| Exchange Rate Effect | -33 | -44 | 234 | -463 | -45 |
| Beginning Cash Position | 227,353 | 596,073 | 688,644 | 476,493 | 70,088 |
| End Cash Position | 359,284 | 227,353 | 596,073 | 688,644 | 476,493 |
| Net Cash Flow | $131,931 | $-368,720 | $-92,571 | $212,151 | $406,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,197 | -33,606 | -21,373 | -217,898 | 34,627 |
| Capital Expenditure | -48,601 | -131,661 | -101,278 | -36,666 | -42,742 |
| Free Cash Flow | -63,798 | -165,267 | -122,651 | -254,564 | -8,115 |